BlackRock Inc. acquired a new position in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 1,582,005 shares of the company's stock, valued at approximately $135,752,000. BlackRock Inc. owned about 5.38% of Establishment Labs as of its most recent SEC filing.
Several other large investors have also bought and sold shares of the stock. Nantahala Capital Management LLC increased its position in shares of Establishment Labs by 11.1% during the third quarter. Nantahala Capital Management LLC now owns 1,973,492 shares of the company's stock worth $80,893,000 after buying an additional 197,962 shares during the period. Bamco Inc. NY raised its position in shares of Establishment Labs by 21.5% in the 2nd quarter. Bamco Inc. NY now owns 907,537 shares of the company's stock worth $38,761,000 after acquiring an additional 160,755 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Establishment Labs by 117.4% during the 4th quarter. Goldman Sachs Group Inc. now owns 811,536 shares of the company's stock valued at $59,145,000 after purchasing an additional 438,206 shares in the last quarter. Mudita Advisors LLP lifted its stake in Establishment Labs by 1.9% in the fourth quarter. Mudita Advisors LLP now owns 699,703 shares of the company's stock valued at $50,994,000 after buying an additional 12,939 shares during the period. Finally, Rice Hall James & Associates LLC bought a new position in shares of Establishment Labs during the 2nd quarter worth approximately $48,134,000. 72.91% of the stock is owned by institutional investors.
Establishment Labs Price Performance
Shares of NASDAQ ESTA opened at $70.64 on Friday. The company has a debt-to-equity ratio of 12.11, a quick ratio of 2.52 and a current ratio of 3.84. Establishment Labs Holdings Inc. has a fifty-two week low of $36.53 and a fifty-two week high of $97.59. The stock has a market cap of $2.11 billion, a PE ratio of -53.92 and a beta of 1.07. The stock has a fifty day moving average of $85.00 and a 200-day moving average of $74.91.
Establishment Labs (NASDAQ:ESTA - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.05). Establishment Labs had a negative return on equity of 196.69% and a negative net margin of 15.82%.The firm had revenue of $67.54 million during the quarter, compared to analysts' expectations of $65.79 million. During the same quarter in the prior year, the company earned ($0.57) earnings per share. The business's revenue for the quarter was up 31.7% compared to the same quarter last year. Equities research analysts anticipate that Establishment Labs Holdings Inc. will post -1.15 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on ESTA shares. BTIG Research boosted their target price on shares of Establishment Labs from $96.00 to $103.00 and gave the company a "buy" rating in a research report on Thursday, August 6th. Citigroup raised Establishment Labs from a "neutral" rating to a "buy" rating and set a $92.00 target price for the company in a research report on Thursday, August 13th. Needham & Company LLC upped their price target on Establishment Labs from $86.00 to $95.00 and gave the stock a "buy" rating in a research note on Thursday, August 6th. TD Cowen increased their price target on Establishment Labs from $95.00 to $117.00 and gave the stock a "buy" rating in a report on Monday, August 3rd. Finally, Mizuho raised their price objective on Establishment Labs from $100.00 to $105.00 and gave the company an "outperform" rating in a research note on Wednesday, July 15th. Eight investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Establishment Labs has an average rating of "Moderate Buy" and a consensus price target of $100.25.
Check Out Our Latest Stock Analysis on ESTA
Establishment Labs Profile
(
Free Report)
Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company's proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.
The company's flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.
Featured Stories
Want to see what other hedge funds are holding ESTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Establishment Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Establishment Labs wasn't on the list.
While Establishment Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
